GlassScriptPhysician profile
Jeffrey T Jacob
NPI 1073715686
$3,931.12
in general payments reported to CMS, 2019-2025
22 companies · $854 in 2025
The $854 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.86 · 2021: $159 · 2022: $597 · 2023: $797 · 2024: $1,498 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,109 · Education: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,109.29 |
| Education | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $725.93 | 2021-2025 | Universal Neuro 3, Adherus Autospray Dural Sealant, Na |
| Medtronic, INC. | $672.04 | 2022-2025 | Stealthstation S8 Platform, Mazor X System |
| Kls-Martin L.P. | $386.44 | 2022-2025 | |
| Depuy Synthes Sales INC. | $297.34 | 2022-2024 | Synthecel, Matrixneuro |
| Kuros Biosciences USA, INC | $221.03 | 2024 | Magnetos |
| Relievant Medsystems, INC. | $175.00 | 2023 | Intracept |
| Innovasis INC | $167.16 | 2022-2024 | |
| Gt Medical Technologies, INC | $159.42 | 2025 | Gammatile |
| Si-Bone, INC. | $155.50 | 2023 | |
| Integra Lifesciences Corporation | $142.80 | 2024-2025 | Codman Hakim, Cusa Clarity, Duraseal Exact Spinal Sealant System |
| Pinnacle, INC | $130.31 | 2024 | |
| Boston Scientific Corporation | $122.27 | 2023 | |
| Acclarent, INC | $112.78 | 2023 | Acclarent Aera, Acclarent Navwire |
| Augmedics INC. | $93.75 | 2024 | Xvision |
| Aesculap, INC. | $92.37 | 2024 | M.Blue |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Longeviti Neuro Solutions INC | $70.00 | 2023 | |
| Carl Zeiss Meditec USA, INC. | $54.58 | 2023 | |
| Mimedx Group, INC. | $43.42 | 2025 | |
| Csl Behring | $40.00 | 2024 | Kcentra |
| Arbor Pharmaceuticals, INC. | $25.86 | 2019 | |
| Abbvie INC. | $23.66 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $19.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.